InsidersTradesSigma
Follow the 경동제약 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 경동제약 has logged 1 reports. Market capitalisation: €142.1bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 류 기 성. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
경동제약 is a company in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the research, development, and manufacturing of pharmaceutical products.